# Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients

> **NCT05026125** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 60 (actual)

## Conditions studied

- Obesity
- Bariatric Surgery Candidate
- Intubation Complication

## Interventions

- **DRUG:** Remifentanil Injection
- **DRUG:** Remifentanil Injection plus 30%

## Key facts

- **NCT ID:** NCT05026125
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-13
- **Primary completion:** 2023-08-11
- **Final completion:** 2023-08-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05026125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05026125, "Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05026125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*